Member

Adaptyx Biosciences


Adaptyx Biosciences develops a wearable platform that turns laboratory-grade biochemical assays into continuous molecular data streams. The company enables minimally invasive, real-time monitoring of diverse biomarkers through programmable molecular sensors combined with advanced electronics and AI-driven analytics. The goal is to provide actionable, continuous health insights for clinicians, facilitating proactive, personalized, and always-on healthcare. The technology is designed for versatility across high-impact use cases such as heart failure management, chronic kidney disease, hormone dysregulation, hospital care and precision drug monitoring. The platform is based on a decade of academic innovation, integrating high-throughput molecular engineering, data-driven design, and robust clinical-grade performance.

Industries

N/A

Adaptyx Biosciences


Patents

Systems and methods for analyte detection

2024-10-08 • US-12109019-B2

View Details

Products

A minimally-invasive wearable device integrating programmable chemistry, electronics, and AI-driven analytics to continuously collect, analyze, and transmit multi-analyte molecular data from interstitial fluid.

Expertise Areas

  • Continuous molecular monitoring
  • Biosensor engineering
  • Digital health data integration
  • Clinical biomarker application
  • Show More (3)

Key Technologies

  • Programmable molecular switches
  • Synthetic DNA-based biosensor architectures
  • Minimally-invasive dermal probes
  • High-throughput biomolecular screening
  • Show More (4)

Key People

Co-Founder & Chief Science Officer

LinkedIn

Co-Founder & Chief Technology Officer

LinkedIn

Chief Medical & Business Officer

LinkedIn

Co-Founder & Scientific Advisor

Co-Founder & Scientific Advisor


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.